Interferon Alfa News and Research

RSS
Viramidine demonstrates anti-HCV Genotype 1 activity that compares favorably to Ribavirin

Viramidine demonstrates anti-HCV Genotype 1 activity that compares favorably to Ribavirin

Vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia

Vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia

Pegylated interferon alfa-2b offers the best treatment option for people with chronic hepatitis B infection

Pegylated interferon alfa-2b offers the best treatment option for people with chronic hepatitis B infection

New approaches for the treatment of chronic hepatitis C

New approaches for the treatment of chronic hepatitis C

Neck surgeons brush up on West Nile virus

Neck surgeons brush up on West Nile virus

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

Treatment helps 26% of black Americans with chronic hepatitis C

Treatment helps 26% of black Americans with chronic hepatitis C

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

Largest study comparing leading hepatitis C treatments

Largest study comparing leading hepatitis C treatments

Schering-Plough submits Japanese application for hepatitis C drug

Schering-Plough submits Japanese application for hepatitis C drug